BIOMAT Database Logo BIOMAT Database Logo

Manic symptoms following addition of lithium to antidepressant treatment. 1984

L H Price, and D S Charney, and G R Heninger

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003891 Desipramine A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. Desmethylimipramine,Apo-Desipramine,Demethylimipramine,Desipramine Hydrochloride,Norpramin,Novo-Desipramine,Nu-Desipramine,PMS-Desipramine,Pertofran,Pertofrane,Pertrofran,Petylyl,Ratio-Desipramine,Apo Desipramine,Hydrochloride, Desipramine,Novo Desipramine,Nu Desipramine,PMS Desipramine,Ratio Desipramine
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000639 Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. Amineurin,Amitrip,Amitriptylin Beta,Amitriptylin Desitin,Amitriptylin RPh,Amitriptylin-Neuraxpharm,Amitriptyline Hydrochloride,Amitrol,Anapsique,Apo-Amitriptyline,Damilen,Domical,Elavil,Endep,Laroxyl,Lentizol,Novoprotect,Saroten,Sarotex,Syneudon,Triptafen,Tryptanol,Tryptine,Tryptizol,Amitriptylin Neuraxpharm,Apo Amitriptyline,Desitin, Amitriptylin,RPh, Amitriptylin
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant

Related Publications

L H Price, and D S Charney, and G R Heninger
The addition of olanzapine to valproate or lithium for acute manic or mixed bipolar episodes reduced manic symptoms.
August 2002, Evidence-based mental health,
L H Price, and D S Charney, and G R Heninger
Parkinsonian symptoms with lithium, lithium-neuroleptic, and lithium-antidepressant treatment.
May 1983, Journal of affective disorders,
L H Price, and D S Charney, and G R Heninger
The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression.
September 1989, Archives of general psychiatry,
L H Price, and D S Charney, and G R Heninger
[Successful lithium treatment of manic-like symptoms in multiple sclerosis].
April 1984, Der Nervenarzt,
L H Price, and D S Charney, and G R Heninger
Rapid antidepressant effect of addition of lithium to tranylcypromine.
June 1986, Journal of clinical psychopharmacology,
L H Price, and D S Charney, and G R Heninger
LITHIUM TREATMENT OF MANIC STATES.
January 1964, Postgraduate medicine,
L H Price, and D S Charney, and G R Heninger
Extrapyramidal symptoms with addition of lithium to neuroleptics.
November 1989, The Journal of nervous and mental disease,
L H Price, and D S Charney, and G R Heninger
Lithium addition to a tricyclic antidepressant results in optimal efficacy.
January 2011, Acta psychiatrica Scandinavica,
L H Price, and D S Charney, and G R Heninger
Rubidium and lithium: evaluation as antidepressant and anti-manic agents.
July 1973, Research communications in chemical pathology and pharmacology,
L H Price, and D S Charney, and G R Heninger
Increased extrapyramidal symptoms with addition of lithium to neuroleptics.
November 1988, The Journal of nervous and mental disease,
Copied contents to your clipboard!